Statement of deviation or variation as on March 31, 2025 from utilization of funds raised through IPO
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory has filed its quarterly statement on the use of funds raised through its IPO, which closed in July 2024 with a total raise of INR 578.30 Lakhs. The original objects of the issue were expansion of diagnostic centres, general corporate purposes, and IPO-related expenses, with the full INR 578.30 Lakhs allocated to these purposes. As on March 31, 2025, the company has utilised INR 378.30 Lakhs (about 65% of the amount raised), with the remaining balance still pending deployment. The filing confirms there is no deviation or variation from the originally stated objects and the audit committee and auditors have raised no concerns. This is a routine SEBI compliance disclosure under Regulation 32 of the Listing Regulations.
This is a standard compliance filing and is neutral for shareholders. It confirms IPO funds are being used as originally disclosed, but investors may note that around 35% of the IPO proceeds are yet to be deployed, which is normal for a recent IPO. No red flags or governance issues have been flagged.